ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
8.98
+0.24 (2.75%)
Nov 21, 2024, 1:38 PM EST - Market open
ORIC Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Cash & Equivalents | 44.23 | 23.38 | 66.84 | 226.01 | 78.45 | 89.16 | Upgrade
|
| Short-Term Investments | 228.14 | 184.8 | 139.43 | 10.97 | 215.15 | - | Upgrade
|
| Cash & Short-Term Investments | 272.37 | 208.19 | 206.27 | 236.98 | 293.6 | 89.16 | Upgrade
|
| Cash Growth | 19.83% | 0.93% | -12.96% | -19.29% | 229.30% | 109.12% | Upgrade
|
| Prepaid Expenses | 7.06 | 4.41 | 4.19 | 3.54 | 3.1 | 0.84 | Upgrade
|
| Total Current Assets | 279.43 | 212.6 | 210.46 | 240.52 | 296.7 | 90 | Upgrade
|
| Property, Plant & Equipment | 3.09 | 12.01 | 14.24 | 14.21 | 1.98 | 2.24 | Upgrade
|
| Long-Term Investments | 10 | 26.85 | 21.95 | 43.39 | - | - | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | - | 1.3 | Upgrade
|
| Other Long-Term Assets | 9.55 | 0.55 | 0.53 | 0.52 | 0.32 | 0.55 | Upgrade
|
| Total Assets | 302.07 | 252.01 | 247.18 | 298.64 | 299 | 94.09 | Upgrade
|
| Accounts Payable | 4.25 | 0.94 | 1.32 | 1.89 | 0.76 | 0.15 | Upgrade
|
| Accrued Expenses | 13.88 | 16.76 | 11.41 | 11.34 | 7.7 | 3.46 | Upgrade
|
| Current Portion of Leases | 3.12 | 2.75 | 2.66 | 1.93 | - | - | Upgrade
|
| Other Current Liabilities | - | - | - | - | 0.55 | 1.74 | Upgrade
|
| Total Current Liabilities | 21.25 | 20.46 | 15.39 | 15.15 | 9 | 5.35 | Upgrade
|
| Long-Term Leases | 6.83 | 7.46 | 9.44 | 10.52 | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 0.22 | 0.77 | Upgrade
|
| Total Liabilities | 28.08 | 27.92 | 24.83 | 25.67 | 9.22 | 6.12 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0 | 0 | - | Upgrade
|
| Additional Paid-In Capital | 799.73 | 658.75 | 557.87 | 518.18 | 456.2 | 2.61 | Upgrade
|
| Retained Earnings | -526.47 | -434.93 | -334.23 | -245.11 | -166.39 | -92.69 | Upgrade
|
| Comprehensive Income & Other | 0.72 | 0.26 | -1.29 | -0.1 | -0.03 | - | Upgrade
|
| Total Common Equity | 273.99 | 224.09 | 222.35 | 272.98 | 289.78 | -90.08 | Upgrade
|
| Shareholders' Equity | 273.99 | 224.09 | 222.35 | 272.98 | 289.78 | 87.97 | Upgrade
|
| Total Liabilities & Equity | 302.07 | 252.01 | 247.18 | 298.64 | 299 | 94.09 | Upgrade
|
| Total Debt | 9.95 | 10.21 | 12.1 | 12.44 | - | - | Upgrade
|
| Net Cash (Debt) | 262.42 | 197.97 | 194.17 | 224.54 | 293.6 | 89.16 | Upgrade
|
| Net Cash Growth | 21.16% | 1.96% | -13.52% | -23.52% | 229.30% | 109.12% | Upgrade
|
| Net Cash Per Share | 3.95 | 3.85 | 4.90 | 5.92 | 13.38 | 46.94 | Upgrade
|
| Filing Date Shares Outstanding | 70.57 | 67.38 | 45.09 | 39.43 | 36.7 | 1.98 | Upgrade
|
| Total Common Shares Outstanding | 70.56 | 54.87 | 45.09 | 39.43 | 36.67 | 1.98 | Upgrade
|
| Working Capital | 258.18 | 192.14 | 195.07 | 225.37 | 287.7 | 84.65 | Upgrade
|
| Book Value Per Share | 3.88 | 4.08 | 4.93 | 6.92 | 7.90 | -45.40 | Upgrade
|
| Tangible Book Value | 273.99 | 224.09 | 222.35 | 272.98 | 289.78 | -90.08 | Upgrade
|
| Tangible Book Value Per Share | 3.88 | 4.08 | 4.93 | 6.92 | 7.90 | -45.40 | Upgrade
|
| Machinery | 8.28 | 7.39 | 7.07 | 5.69 | 4.76 | 4.05 | Upgrade
|
| Leasehold Improvements | 2.03 | 1.97 | 1.98 | 1.71 | 1.71 | 1.71 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.